SOURCES SOUGHT
A -- NIDA Center for Genetic Studies
- Notice Date
- 6/13/2013
- Notice Type
- Sources Sought
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4211 - MSC 9559, Bethesda, Maryland, 20892, United States
- ZIP Code
- 20892
- Solicitation Number
- HHS-NIH-NIDA-SBSS-14-005
- Archive Date
- 7/13/2013
- Point of Contact
- Kara Anderson, Phone: (301) 443-6677, Brian H. O'Laughlin, Phone: (301) 443-6677
- E-Mail Address
-
kara.anderson@nih.gov, olaughlinb@mail.nih.gov
(kara.anderson@nih.gov, olaughlinb@mail.nih.gov)
- Small Business Set-Aside
- N/A
- Description
- SOURCES SOUGHT NOTICE HHS-NIH-NIDA-SBSS-14-005 N01DA-14-7789 FY 2014 - Posted June 13, 2013 Title: NIDA Center for Genetic Studies The National Institute on Drug Abuse, Division of Neuroscience and Behavioral Research, is seeking capability statements from qualified organizations that can maintain and expand the NIDA Center for Genetic Studies, a repository to process, store, and distribute de-identified biological samples and clinical data. This is a SMALL BUSINESS SOURCES SOUGHT NOTICE to determine the availability of all small businesses (e.g., 8(a), Veteran-owned small businesses, service-disabled Veteran-owned small businesses, HUBZone small businesses, small disadvantaged businesses, and women-owned small businesses) that have the capability to maintain and expand the NIDA Center for Genetic Studies. The successful contractor must have the required capabilities and in-depth knowledge in the areas listed below. The contractor is required to process, store, and widely distribute high-quality data files, documentation, and biological materials (cell lines, DNA, RNA, serum) collected from individuals with drug abuse and addiction-related disorders and their relatives. NIDA expects to receive a volume of approximately 10,000 samples over the next 5 years. To date, over 50,000 samples already have been collected. The total number of samples by the end of the contract period is expected to be between 60,000 and 65,000 samples. Interested small business organizations must be able to demonstrate in their capability statements the ability of the laboratory to maintain and expand the sample volume described here, as well as have extensive experience (lead investigator must have extensive experience in biospecimen processing and data management, and have support staff well-trained in human subject data collection, blood sample handling, and cell line generation). Prior to the award of any contract, the repository would need to possess a Certificate of Confidentiality and approval from the U.S. Department of Veterans Affairs. Interested small business also must have expertise in the following areas: 1. Competence and experience in molecular biological and molecular genetic techniques, including microarray analyses, genomic sequencing, creation of reprogrammed cellular derivatives (i.e., induced pluripotent stem cells, also known as iPSC), biological specimen processing, extraction, irradiated feeder technology, and dissemination, as well as preparing pedigree files and files used to conduct statistical genetic analyses suitable for publication in peer-reviewed journals. 2. Expertise conducting quantitative genetic research on common, complex human disorders, including the analysis of data generated from genome-wide scans, as evidenced by publications in peer-reviewed scientific publications. 3. Availability and competence of the investigative team. 4. Ability and experience to efficiently create comprehensive documentation of phenotypic and genotypic databases. Capability statements should be relevant and specific in the technical area under consideration on each of the following qualifications: 1) Experience: An outline of previous similar projects, specifically the techniques employed in the areas described above; 2) Personnel: Name; professional qualifications; specific experience in the work requested; and knowledge of drug abuse. We will consider appropriateness of professional and technical personnel classifications. We will consider any other specific and relevant information about this particular announcement that would improve our evaluation of respondents. Organizations should demonstrate capability to administer and coordinate interrelated tasks in an effective and timely manner. Documentation may include, but is not limited to, contracts in which the organization performed (Government and commercial); references, i.e., names, titles, telephone numbers and any other information serving to document the organizations capability; and awards or commendations. The established NAICS code is 541712: Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology). The U.S. Small Business Administration establishes a size standard for 541712 of 500 employees or fewer. All capability statements also should include the following: 1) company name and address; 2) point of contact, 3) phone/fax/email; 4) NAICS Code(s), 5) business size and status; 6) capability information in response to the requirement and qualifications identified in this notice; and 7) type(s) of business, if any (e.g.,: small, Veteran-owned, service-disabled Veteran-Owned, women-owned, 8(a), Small Disadvantaged Business (SDB), and Historically Underutilized Business Zone (HUBZone). THIS IS NOT A REQUEST FOR PROPOSALS: This notice is for information and planning purposes only and does not commit the Government to any contractual agreement. The Government does not intend to award a contract based on responses under this announcement nor otherwise pay for the preparation of any information sent for the Government's use. Small business concerns that believe they possess the capability necessary to successfully undertake the work described above must submit capability statements to Kara Anderson, whose contact information is below, NO LATER THAN June 27, 2013. Any proprietary information should be so marked. NIDA will accept paper or electronic capability statements. Contracting Office Address: NIDA R&D Contracts Management Branch Office of Acquisitions, NIDA, NIH 6001 Executive Blvd, Room 4211, MSC 9559 Bethesda, MD 20892-9559* * FedEx/UPS/Courier/Hand Delivery: Rockville, MD 20852
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-01/HHS-NIH-NIDA-SBSS-14-005/listing.html)
- Record
- SN03088409-W 20130615/130613235201-d564c16e0d55c298fbd37154c1d31950 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |